Covered recipient · General Payments record
DAVID BINDER
Allopathic & Osteopathic Physicians Obstetrics & Gynecology
General Payments · PY2018–2023
$2,257.02
- Reported across 142 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2023 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $311.25 | 17 |
By paying entity
PY2023 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $100.77 | 6 |
| Exeltis, USA Inc. | $70.06 | 4 |
| MAYNE PHARMA COMMERCIAL LLC | $40.51 | 2 |
| Sumitomo Pharma America, Inc. | $29.49 | 1 |
| Astellas Pharma US Inc | $27.37 | 1 |
| CooperSurgical, Inc. | $15.34 | 1 |
| Mycovia Pharmaceuticals, Inc. | $14.61 | 1 |
| PFIZER INC. | $13.10 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2023 (17)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| AbbVie Inc. | $17.54 | 01/04/2023 | Food and Beverage | Undisputed | 01/23/2026 | 996259901 | CMS |
| AbbVie Inc. | $24.95 | 01/31/2023 | Food and Beverage | Undisputed | 01/23/2026 | 996259903 | CMS |
| AbbVie Inc. | $14.17 | 05/10/2023 | Food and Beverage | Undisputed | 01/23/2026 | 996259905 | CMS |
| AbbVie Inc. | $16.99 | 08/17/2023 | Food and Beverage | Undisputed | 01/23/2026 | 996259907 | CMS |
| AbbVie Inc. | $13.65 | 10/23/2023 | Food and Beverage | Undisputed | 01/23/2026 | 996259909 | CMS |
| AbbVie Inc. | $13.47 | 11/08/2023 | Food and Beverage | Undisputed | 01/23/2026 | 996259911 | CMS |
| Astellas Pharma US Inc | $27.37 | 06/14/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1034170163 | CMS |
| CooperSurgical, Inc. | $15.34 | 11/09/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1051530633 | CMS |
| Exeltis, USA Inc. | $14.26 | 01/11/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1002210506 | CMS |
| Exeltis, USA Inc. | $13.04 | 01/24/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1002103139 | CMS |
| Exeltis, USA Inc. | $23.89 | 09/06/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1002113821 | CMS |
| Exeltis, USA Inc. | $18.87 | 11/29/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1002170415 | CMS |
| MAYNE PHARMA COMMERCIAL LLC | $20.87 | 09/11/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1060930611 | CMS |
| MAYNE PHARMA COMMERCIAL LLC | $19.64 | 10/06/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1060930609 | CMS |
| Mycovia Pharmaceuticals, Inc. | $14.61 | 05/14/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1030682547 | CMS |
| PFIZER INC. | $13.10 | 02/22/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1049558907 | CMS |
| Sumitomo Pharma America, Inc. | $29.49 | 08/02/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1031004831 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023
- Generated from
- OP_DTL_GNRL_PGYR2023_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.